It is also time to address the matter of volume, said Mr. Tryfon, and for once more went on to call for all healthcare providers, not just the pharmaceutical industry, to contribute equally to expenditure cutbacks.
He underlined that of the €2 billion budget allocated to healthcare expenditure in 2014, Greek Pharma companies claimed 35%.
With regard to matters of development, Mr. Tryfon was keen to point out that, "It's been three years now – lest we say 13 – that companies have been doing nothing but crisis management, which allows no opportunity for strategic development. If we continue to deal with problems based on a crisis management rationale, he went on to say, "the country will be hopeless". We are working under a regime of limited access to resources, he concluded, but this does not imply that we should neglect prevention.